Diabetes Australia expands its Aboriginal and Torres Strait Islander leadership team 12 August 2020 Diabetes Australia continues to enhance its Aboriginal and Torres Strait Islander leadership team with the appointment of widely respected Kamilaroi-Yuwaalaraay diabetes educator Grace Ward. Aboriginal and Torres Strait Islander Engagement Manager Chris Lee said Grace brought a wealth of experience in First Nations diabetes management and engagement to Diabetes Australia. “Grace joins Diabetes Australia from the highly-regarded Menzies School of Health Research where she facilitated training to support health workers in First Nations communities across Queensland,” Mr Lee said. “Prior to this, Grace worked with Diabetes Queensland facilitating innovative culturally-appropriate First Nations diabetes education programs including Feltman and Got Suga. “Her work with the Australian Diabetes Educators Association, the Indigenous Allied Health Australia and the National Aboriginal and Torres Strait Islander Health Worker Association has been instrumental in helping more First Nations health workers qualify for credentialing as diabetes educators.” Ms Ward said she was excited to join Diabetes Australia and embark on a new chapter of her career. “Diabetes has a major impact on the health of many First Nation’s people including being a leading cause of blindness, heart and kidney failure and that’s why I’ve devoted my career to working with people and communities to reduce this impact,” Mrs Ward said. “Building a better future for our young people is something I’m very passionate about and I’m looking forward to working with Diabetes Australia to deliver real change.”
News 10 November 2023 ‘Green lane’ for people with diabetes to navigate airport security Some Australians living with diabetes are experiencing distress getting through airport security screening, so Diabetes Australia is taking action to educate workers and improve the experience for people living with diabetes. Continue Reading
News 18 September 2023 Fiasp insulin to remain on the Pharmaceutical Benefits Scheme Diabetes Australia has welcomed the announcement by Minister for Health and Aged Care, Hon Mark Butler MP, that Fiasp insulin will continue to be available on the Pharmaceutical Benefits Scheme (PBS) from 1 October 2023. Continue Reading
News 17 August 2023 Update on Fiasp insulin Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. Continue Reading